Logo image of MRK

MERCK & CO. INC. (MRK) Stock Price, Quote, News and Overview

NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock - Currency: USD

81.71  -0.11 (-0.13%)

After market: 81.81 +0.1 (+0.12%)

MRK Quote, Performance and Key Statistics

MERCK & CO. INC.

NYSE:MRK (6/13/2025, 3:42:27 PM)

After market: 81.81 +0.1 (+0.12%)

81.71

-0.11 (-0.13%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High134.63
52 Week Low73.31
Market Cap205.18B
Shares2.51B
Float2.51B
Yearly Dividend3.1
Dividend Yield4.17%
PE10.49
Fwd PE8.29
Earnings (Next)07-29 2025-07-29/bmo
IPO01-01 1941-01-01


MRK short term performance overview.The bars show the price performance of MRK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10

MRK long term performance overview.The bars show the price performance of MRK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MRK is 81.71 USD. In the past month the price increased by 11.37%. In the past year, price decreased by -36.81%.

MERCK & CO. INC. / MRK Daily stock chart

MRK Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 59.55 776.54B
JNJ JOHNSON & JOHNSON 15.63 377.99B
NVO NOVO-NORDISK A/S-SPONS ADR 21.87 354.71B
NVS NOVARTIS AG-SPONSORED ADR 14.37 235.92B
AZN ASTRAZENECA PLC-SPONS ADR 16.91 230.73B
PFE PFIZER INC 7.64 139.52B
SNY SANOFI-ADR 10.99 120.88B
BMY BRISTOL-MYERS SQUIBB CO 6.78 101.25B
GSK GSK PLC-SPON ADR 9.14 82.81B
ZTS ZOETIS INC 27.3 73.16B
HLN HALEON PLC-ADR 21.74 48.91B
TAK TAKEDA PHARMACEUTIC-SP ADR 63.33 47.48B

About MRK

Company Profile

MRK logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY 07033 US

CEO: Kenneth C. Frazier

Employees: 74000

MRK Company Website

MRK Investor Relations

Phone: 19087404000

MERCK & CO. INC. / MRK FAQ

What is the stock price of MERCK & CO. INC. today?

The current stock price of MRK is 81.71 USD. The price decreased by -0.13% in the last trading session.


What is the ticker symbol for MERCK & CO. INC. stock?

The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is MRK stock listed?

MRK stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for MERCK & CO. INC. stock?

32 analysts have analysed MRK and the average price target is 104.83 USD. This implies a price increase of 28.3% is expected in the next year compared to the current price of 81.71. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (MRK) has a market capitalization of 205.18B USD. This makes MRK a Mega Cap stock.


How many employees does MERCK & CO. INC. have?

MERCK & CO. INC. (MRK) currently has 74000 employees.


What are the support and resistance levels for MERCK & CO. INC. (MRK) stock?

MERCK & CO. INC. (MRK) has a support level at 81.81 and a resistance level at 81.83. Check the full technical report for a detailed analysis of MRK support and resistance levels.


Is MERCK & CO. INC. (MRK) expected to grow?

The Revenue of MERCK & CO. INC. (MRK) is expected to grow by 1.67% in the next year. Check the estimates tab for more information on the MRK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MERCK & CO. INC. (MRK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MERCK & CO. INC. (MRK) stock pay dividends?

MERCK & CO. INC. (MRK) has a dividend yield of 4.17%. The yearly dividend amount is currently 3.1. Check the full fundamental report for a detailed analysis of MRK dividend history, reliability and sustainability.


When does MERCK & CO. INC. (MRK) report earnings?

MERCK & CO. INC. (MRK) will report earnings on 2025-07-29, before the market open.


What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (MRK)?

The PE ratio for MERCK & CO. INC. (MRK) is 10.49. This is based on the reported non-GAAP earnings per share of 7.79 and the current share price of 81.71 USD. Check the full fundamental report for a full analysis of the valuation metrics for MRK.


What is the Short Interest ratio of MERCK & CO. INC. (MRK) stock?

The outstanding short interest for MERCK & CO. INC. (MRK) is 1.64% of its float. Check the ownership tab for more information on the MRK short interest.


MRK Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to MRK. When comparing the yearly performance of all stocks, MRK is a bad performer in the overall market: 88.92% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MRK Fundamental Analysis

ChartMill assigns a fundamental rating of 8 / 10 to MRK. Both the health and profitability get an excellent rating, making MRK a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MRK Financial Highlights

Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.79. The EPS increased by 258.99% compared to the year before.


Industry RankSector Rank
PM (TTM) 27.27%
ROA 15.14%
ROE 36.07%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%7.25%
Sales Q2Q%-1.56%
EPS 1Y (TTM)258.99%
Revenue 1Y (TTM)4.1%

MRK Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 77% to MRK. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 17.73% and a revenue growth 1.67% for MRK


Ownership
Inst Owners79.95%
Ins Owners0.05%
Short Float %1.64%
Short Ratio2.44
Analysts
Analysts76.88
Price Target104.83 (28.3%)
EPS Next Y17.73%
Revenue Next Year1.67%